![Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy | Circulation: Heart Failure Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy | Circulation: Heart Failure](https://www.ahajournals.org/cms/asset/8acebbc0-9123-4caa-9da6-8eb57923f203/hhf0051002650001.jpeg)
Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy | Circulation: Heart Failure
![3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase | Journal of Medicinal Chemistry 3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm050855s/asset/images/medium/jm050855su00005a.gif)
3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase | Journal of Medicinal Chemistry
![2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and](https://www.ahajournals.org/cms/asset/fd67787e-d1ff-4243-b314-db3f6a38729b/cir.0000000000000509.fp.png)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and
![Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. | Circulation Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. | Circulation](https://www.ahajournals.org/cms/asset/548c3034-2183-42ac-861d-ea624eb65ef3/01.cir.60.6.1208.fp.png)
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. | Circulation
![3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase | Journal of Medicinal Chemistry 3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm050855s/asset/images/medium/jm050855sf1.gif)